Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-10-01
|
| Series: | Atherosclerosis Plus |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667089522000244 |
| _version_ | 1798028798394892288 |
|---|---|
| author | J. Cegla L. d’Erasmo K. Steward A. di Costanzo E. Boersma M. Arca J. Roeters van Lennep |
| author_facet | J. Cegla L. d’Erasmo K. Steward A. di Costanzo E. Boersma M. Arca J. Roeters van Lennep |
| author_sort | J. Cegla |
| collection | DOAJ |
| first_indexed | 2024-04-11T19:14:02Z |
| format | Article |
| id | doaj.art-167af377baf54039b186749e6d49632f |
| institution | Directory Open Access Journal |
| issn | 2667-0895 |
| language | English |
| last_indexed | 2024-04-11T19:14:02Z |
| publishDate | 2022-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Atherosclerosis Plus |
| spelling | doaj.art-167af377baf54039b186749e6d49632f2022-12-22T04:07:28ZengElsevierAtherosclerosis Plus2667-08952022-10-0149S2S3Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European studyJ. Cegla0L. d’Erasmo1K. Steward2A. di Costanzo3E. Boersma4M. Arca5J. Roeters van Lennep6Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UKDepartment of Internal Medicine and Clinical Specialties, Sapienza University of Rome, Rome, ItalyDepartment of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam, the NetherlandsDepartment of Internal Medicine and Clinical Specialties, Sapienza University of Rome, Rome, ItalyDepartment of Cardiology, Erasmus MC, University Medical Centre Rotterdam, the NetherlandsDepartment of Internal Medicine and Clinical Specialties, Sapienza University of Rome, Rome, ItalyDepartment of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam, the Netherlandshttp://www.sciencedirect.com/science/article/pii/S2667089522000244 |
| spellingShingle | J. Cegla L. d’Erasmo K. Steward A. di Costanzo E. Boersma M. Arca J. Roeters van Lennep Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study Atherosclerosis Plus |
| title | Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study |
| title_full | Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study |
| title_fullStr | Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study |
| title_full_unstemmed | Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study |
| title_short | Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study |
| title_sort | lomitapide in the long term real world management of hofh effectiveness tolerability and hepatic safety from the pan european study |
| url | http://www.sciencedirect.com/science/article/pii/S2667089522000244 |
| work_keys_str_mv | AT jcegla lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy AT lderasmo lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy AT ksteward lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy AT adicostanzo lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy AT eboersma lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy AT marca lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy AT jroetersvanlennep lomitapideinthelongtermrealworldmanagementofhofheffectivenesstolerabilityandhepaticsafetyfromthepaneuropeanstudy |